Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-06
2006-06-06
Brumback, Brenda (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S399000, C530S402000
Reexamination Certificate
active
07056885
ABSTRACT:
The present invention provides FGF-CX polypeptides and polynucleotides, and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods of use for the FGF-CX polypeptide, polynucleotide and antibody.
REFERENCES:
patent: 5512460 (1996-04-01), Nauro et al.
patent: 2002/0001825 (2002-01-01), Itoh
patent: WO 00/54813 (2000-09-01), None
patent: WO 01/07595 (2001-02-01), None
patent: WO 01/31008 (2001-05-01), None
patent: WO 01/68854 (2001-09-01), None
patent: WO 01/72957 (2001-10-01), None
patent: WO 01/92522 (2001-12-01), None
patent: WO 02/02625 (2002-01-01), None
patent: WO 02/24234 (2002-03-01), None
Galzie et al. Biochem. Cell Biol. 75: 669-685, 1997.
U.S. Appl. No. 60/161,162, filed Oct. 22, 1999, Itoh et al.
U.S. Appl. No. 60/124,460, filed Mar. 15, 1999, Manning et al.
Pickering, et al. (1997). “Fibroblast Growth Factor-2 Potentiates Vascular Smooth Muscle Cell Migration to Platelet-Derived Growth Factor” and “Upregulation of α2β1Integrin and Disassembly of Actin Filaments”Cir. Res. 80:627-637.
Klein, et al. (1995). “Differential Modulation of Cell Phenotype by Different Molecular Weight Forms of Basic Fibroblast Growth Factor: Possible Intracellular Signaling by the High Molecular Weight Forms”J. Cell Biol. Apr; 129(1):233-43.
Basilico and Moscatelli (1992). “The FGF Family of Growth Factors and Ocogenes”Advances in Cancer Research 59: 115-165.
Kirikoshi, et al. (2000). “Molecular Cloning and Characterization of Human FGF-20 on Chromosome 8p21.3-p22”Biochem. Biophys. Res. Commun. 274: 337-343.
Bange et al. (2002).Cancer Res 62: 840-847.
Ohmachi et al. (2000).Biochemical and Biophysical Res Comm 277: 355-360.
Wong et al. (2001).Am J of Medical Genetics 102: 282-285.
International Search Report for PCT/US02/19400, mailed Jun. 4, 2003.
Bikfalvi, et al. (1997). Endocrine Reviews 18: 26-45.
Kirikoshi, et al. (2000). Biochem and Biophys Res Comm 274: 337-343.
Boldog Ferenc L.
Burgess Catherine
Fernandes Elma
Herrmann John L.
Jeffers Michael
Biswas, Esq. Naomi S.
Brumback Brenda
CuraGen Corporation
Elrifi, Esq. Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Fibroblast growth factor and nucleic acids encoding same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibroblast growth factor and nucleic acids encoding same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor and nucleic acids encoding same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707844